 |
| August
28, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
Jason Cole, CEO and Board Member, Zag Bio,
Inc. |
| In
this week’s CEO Q&A, Cole, who lives
with type 1 diabetes himself, discusses
the science behind Zag’s thymus-targeted
platform, what differentiates its approach
from other immune-tolerance strategies in
development, and his outlook for turning
immune tolerance from long-standing
scientific aspiration into real therapies
for patients. More |
|
|
- FDA: Issues Emergency Use Authorization for
Generic Drug to Prevent New World Screwworm in
Cattle More
- Medifast: Launch of the Medifast Metabolic
Health Institute More
- Novavax: Partnership Strategy
Continues to Deliver With XFG-adapted
Nuvaxovid Approvals in the U.S., EU and
Japan for 2026-2027 Vaccination Season More
- Protaryx Medical: First U.S. Commercial
Cases With Its Transseptal Puncture Device More
- Quoin Pharmaceuticals: Positive
Interim Data From Ongoing Phase 2/3 Study of
QRX003 in Netherton Syndrome More
- United Therapeutics: Presents Data at The
European Society of Cardiology Congress 2026
and The European Respiratory Society
International Congress 2026 More
|
|
|
|
- LSN: Hot Investor Mandates (Updated 8/25) More
- More on McKesson Making $2.25Bn Bet on
Precision Medicine’s Future More
- Quoin Pharmaceuticals: Private Placement
Financing of Up to $50.0 Million More
|
|
- Big4Bio CEO Weekly Q&A: Jason
Cole, CEO and Board Member, Zag Bio, Inc.
More
- BioPharmGuy News: 2nd Place Finish, Sugar
Problems, Ghost Roast, Mummy Issues, Fruit
Buds More
- Biotech & Pharma Updates | August 27,
2026 More
- Rare Disease at FDA: Two Frameworks, One
Queue More*
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
- Chutes & Ladders—Vivace Revs Up C-Suite
Ahead of Pivotal Push
More
- Daiichi Sankyo to Give Commercial Team a
Makeover; Novo Nordisk’s GPCR Partner Finds
CMO More*
- OPPORTUNITY: Chief Operating Officer, Remote
More
- OPPORTUNITY: Computational Scientist, New
York More
- OPPORTUNITY: Head of
Computational Method Development, Boston
More
- Rose BioSolutions: Appoints Thomas VanCott,
Ph.D., as Head of HemaCare
More
More
- Slone Partners: Fractional
Leadership in Biotech and Life Sciences -
When it Works and Why More
- Slone Partners: Places Farhad Ghavami as
Chief Executive Officer at SeqCenter More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Capital Region Life
Science Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Capital
Region, all rights reserved
2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
